Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Bicycle Therapeutics PLC Sponsored ADR (BCYC) Debt to Equity Ratio data is not available for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$47.95M |
|
$-20.15M |
|
-- |
|
$47.95M |
|
$72.66M |
|
$-24.71M |
|
$5.82M |
|
$-18.89M |
|
$-18.89M |
|
$-20.15M |
|
$-20.15M |
|
$-20.15M |
|
$-20.15M |
|
$-24.71M |
|
$-23.37M |
|
69.28M |
|
69.28M |
|
$-0.29 |
|
$-0.29 |
|
| Balance Sheet Financials | |
$682.88M |
|
$6.02M |
|
$34.71M |
|
$717.60M |
|
$56.98M |
|
-- |
|
$50.64M |
|
$107.62M |
|
$609.98M |
|
$609.98M |
|
$609.98M |
|
69.37M |
|
| Cash Flow Statement Financials | |
$-249.68M |
|
$-2.35M |
|
$-0.13M |
|
$880.07M |
|
$628.72M |
|
$-251.35M |
|
$39.46M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.98 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
-- |
100.00% |
|
-51.52% |
|
-51.52% |
|
-- |
|
-39.39% |
|
-42.03% |
|
$-252.03M |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
-- |
|
1.35 |
|
66.80 |
|
-3.30% |
|
-3.30% |
|
-2.81% |
|
-3.30% |
|
$8.79 |
|
$-3.64 |
|
$-3.60 |
|